RESUMO
Trichinella spiralis is an intestinal nematode parasite that can cause trichinellosis in humans and animals worldwide. The most important known hosts of T. spiralis are pigs, horses, dogs and cats. Pork and its products are the main sources of infection in human trichinellosis. Vaccines against these infections are urgently needed. In this study, the genes encoding the 43-kDa or 45-kDa glycoprotein present in the excretory-secretory (ES) products from T. spiralis muscle larvae (ML) were cloned into the eukaryotic expression vector pVAX1, resulting plasmids pVAX1-Ts43 and pVAX1-Ts45, respectively. Then BALB/c mice were intramuscularly immunized with the DNA vaccine pVAX1-Ts43, pVAX1-Ts45, or both to evaluate their immunogenicity and host protective potential. After the third immunization, mice of each group were challenged with 300â¯T. spiralis ML. The results showed that the mice immunized with the DNA vaccine pVAX1-Ts43 or pVAX1-Ts45 developed significant numbers of FAS+PNA+ B220+ B cells indicating the formation of the germinal centers (GCs), IFN-γ-secreting (mesenteric lymph nodes, MLN) cells, and IL-4-, and IL-10-secreting splenocytes. Mice immunized with the pVAX1-Ts43 or pVAX1-Ts45 vaccine elicited partial protective immunity against challenge infections with T. spiralis as shown by significant reduction in ML. Most notably, the combined immunity of pVAX1-Ts43 and pVAX1-Ts45 induced better immune responses than either of the DNA vaccines given alone and provided as high as 75.9% reductions in muscle larval burden. These results suggest that the plasmid DNA encoding the 43-kDa or 45-kDa glycoprotein could be considered as a potential vaccine candidate against T. Spiraling infection.
Assuntos
Anticorpos Anti-Helmínticos/imunologia , Trichinella spiralis/imunologia , Triquinelose/prevenção & controle , Vacinas/imunologia , Animais , Anticorpos Anti-Helmínticos/genética , DNA de Helmintos/genética , DNA de Helmintos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Trichinella spiralis/genética , Vacinação , Vacinas de DNA/imunologiaRESUMO
BACKGROUND: Wuchereria bancrofti, Brugia malayi and Brugia timori infect over 100 million people worldwide and are the causative agents of lymphatic filariasis. Some parasite carriers are amicrofilaremic whilst others facilitate mosquito-based disease transmission through blood-circulating microfilariae (Mf). Recent findings, obtained largely from animal model systems, suggest that polymorphonuclear leukocytes (PMNs) contribute to parasitic nematode-directed type 2 immune responses. When exposed to certain pathogens PMNs release extracellular traps (NETs) in the form of chromatin loaded with various antimicrobial molecules and proteases. PRINCIPAL FINDINGS: In vitro, PMNs expel large amounts of NETs that capture but do not kill B. malayi Mf. NET morphology was confirmed by fluorescence imaging of worm-NET aggregates labelled with DAPI and antibodies to human neutrophil elastase, myeloperoxidase and citrullinated histone H4. A fluorescent, extracellular DNA release assay was used to quantify and observe Mf induced NETosis over time. Blinded video analyses of PMN-to-worm attachment and worm survival during Mf-leukocyte co-culture demonstrated that DNase treatment eliminates PMN attachment in the absence of serum, autologous serum bolsters both PMN attachment and PMN plus peripheral blood mononuclear cell (PBMC) mediated Mf killing, and serum heat inactivation inhibits both PMN attachment and Mf killing. Despite the effects of heat inactivation, the complement inhibitor compstatin did not impede Mf killing and had little effect on PMN attachment. Both human PMNs and monocytes, but not lymphocytes, are able to kill B. malayi Mf in vitro and NETosis does not significantly contribute to this killing. Leukocytes derived from presumably parasite-naïve U.S. resident donors vary in their ability to kill Mf in vitro, which may reflect the pathological heterogeneity associated with filarial parasitic infections. CONCLUSIONS/SIGNIFICANCE: Human innate immune cells are able to recognize, attach to and kill B. malayi microfilariae in an in vitro system. This suggests that, in vivo, the parasites can evade this ability, or that only some human hosts support an infection with circulating Mf.
Assuntos
Brugia Malayi/imunologia , DNA de Helmintos/imunologia , Armadilhas Extracelulares/imunologia , Filariose/imunologia , Microfilárias/imunologia , Neutrófilos/imunologia , Animais , Brugia Malayi/genética , Brugia Malayi/fisiologia , DNA de Helmintos/genética , Armadilhas Extracelulares/parasitologia , Filariose/parasitologia , Gerbillinae , Humanos , Leucócitos Mononucleares/imunologia , Microfilárias/genética , Microfilárias/fisiologiaRESUMO
Ts87 is an immunodominant antigen that induces protective immunity against Trichinella spiralis larval challenge in mice. To determine if a combination of recombinant Ts87 protein and its coding DNA induces a stronger immune response in female C57BL/6 mice were immunized with 100 µg of recombinant Ts87 protein plus its coding DNA cloned in vector pVAX1, or the same amount of recombinant protein or DNA only. Mouse subclass IgG responses showed that both co-immunized and single-immunized mice produced a balanced IgG2a/IgG1 (Th1/Th2) response. T-cell proliferation in co-immunized animals was significantly higher than in single-immunized mice. Cytokine profiling in the co-immunization group showed a significant increase in the levels of IL-2, IL-4, IL-6 and IFN-γ in the splenocytes of mice upon stimulation with the recombinant Ts87 protein; however, the expression of IL-17 was down-regulated. Challenge results showed that mice immunized with the recombinant Ts87 protein and its coding DNA produced reduced the muscle larval burden to a greater extent (43.8%) than the groups immunized with only the protein (39.7%) or the DNA (9.7%). A better Th1/Th2 immune response and consequent protection induced by co-immunization with the recombinant Ts87 protein and its coding DNA may result from an adjuvant effect of DNA and a specific persistent expression of Ts87.
Assuntos
Citocinas/metabolismo , DNA de Helmintos/imunologia , Proteínas de Helminto/imunologia , Trichinella spiralis/imunologia , Triquinelose/prevenção & controle , Vacinas de DNA/imunologia , Animais , Proliferação de Células , DNA de Helmintos/genética , Feminino , Vetores Genéticos , Proteínas de Helminto/genética , Camundongos , Camundongos Endogâmicos C57BL , Músculos/parasitologia , Proteínas Recombinantes , Trichinella spiralis/genética , Triquinelose/parasitologia , Vacinação , Vacinas de DNA/genéticaRESUMO
Trichinellosis has major economic impacts on animal husbandry and food safety, and the control and elimination of trichinellosis is a major objective of veterinary medicine. A gene encoding serine protease of Trichinella spiralis (Ts-Adsp) was identified by immunoscreening an adult T. spiralis cDNA library. In this study, the recombinant Ts-Adsp protein (rTs-Adsp) was cloned and expressed in a prokaryotic expression system and purified by Ni-affinity chromatography. To determine whether the purified rTs-Adsp is a potential vaccine candidate for the control of T. spiralis infection, we immunized BALB/c mice with this protein in combination with an alum adjuvant and subsequently challenged with T. spiralis larvae. The results showed that mice vaccinated with rTs-Adsp exhibited an average reduction in the muscle larvae burden of 46.5% relative to the control group. Immunization with the rTs-Adsp antigen induced both humoral and cellular immune responses, which manifested as elevated specific anti-rTs-Adsp IgG and IgE antibodies and a mixed Th1-Th2 response, as determined by Th1 (IFN-γ and IL-2) and Th2 (IL-4, IL-10, and IL-13) cytokine profiling, with the Th2 predominant. Thus, purified rTs-Adsp is able to limit the invasion of T. spiralis , and this protein could be an effective vaccine candidate for trichinellosis.
Assuntos
Antígenos de Helmintos/imunologia , Serina Proteases/imunologia , Trichinella spiralis/imunologia , Triquinelose/prevenção & controle , Vacinas de DNA , Animais , Anticorpos Anti-Helmínticos/sangue , Antígenos de Helmintos/administração & dosagem , Antígenos de Helmintos/genética , Relação CD4-CD8 , Citocinas/metabolismo , DNA Complementar/administração & dosagem , DNA Complementar/imunologia , DNA de Helmintos/administração & dosagem , DNA de Helmintos/imunologia , Feminino , Regulação da Expressão Gênica , Imunoglobulina E/sangue , Imunoglobulina G/sangue , Camundongos , Camundongos Endogâmicos BALB C , Ratos , Ratos Wistar , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/imunologia , Serina Proteases/administração & dosagem , Serina Proteases/genética , Baço/citologia , Baço/imunologia , Trichinella spiralis/enzimologia , Trichinella spiralis/genética , Triquinelose/imunologia , Vacinação , Vacinas de DNA/administração & dosagem , Vacinas de DNA/imunologiaRESUMO
Biolistic vaccination using gene gun is developed as a safer tool for delivery of DNA vaccines, a technique that combines high vaccine efficiency with lower antigen dosage and lower cost per vaccine dose. In this study, we compared the protective responses in mice after delivering the Brugia malayi abundant larval transcript-2 (BmALT-2) DNA vaccine using the conventional intradermal approach or with the needleless gene gun delivery approach. BmALT-2 is a leading vaccine candidate against B. malayi, a lymphatic filarial parasite of human. After optimizing the DNA dose and gene gun parameters for delivery into mouse skin, groups of mice were biolistically vaccinated with 5 µg of BmALT-2pVAX. Groups of mice vaccinated intradermally with 5 µg or 100 µg of BmALT-2pVAX was used for comparison of vaccine efficacy. Results demonstrated that gene gun vaccination with 5 µg of BmALT-2pVAX conferred significant protection against challenge infection that was comparable to the degree of protection conferred by intradermal vaccination with 100 µg of BmALT-2pVAX. This observation was further supported by an in vitro antibody dependent cellular cytotoxicity (ADCC) assay. Analysis of the immune response showed that the gene gun vaccination predominantly induced an IgG1 antibody response and significantly high Th2 cytokine response (IL-4) from spleen cells compared to intradermal BmALT-2 DNA delivery that induced predominantly an IgG2a and Th1 cytokine response (IFN-γ, IL-12 and TNF-α). These findings show that host protective responses could be achieved with 20 fold decrease in DNA dose using a gene gun and could prove to be an efficient delivery method in BmALT-2 DNA vaccination against lymphatic filariasis.
Assuntos
Antígenos de Helmintos/imunologia , Biolística/métodos , Filariose Linfática/prevenção & controle , Proteínas Recombinantes/imunologia , Vacinas de DNA/imunologia , Vacinas/imunologia , Animais , Anticorpos Anti-Helmínticos/imunologia , Antígenos de Helmintos/genética , Células COS , Chlorocebus aethiops , DNA de Helmintos/imunologia , Imunoglobulina G/imunologia , Injeções Intradérmicas , Interferon gama/imunologia , Interleucina-12/imunologia , Interleucina-4/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Recombinantes/genética , Fator de Necrose Tumoral alfa/imunologiaRESUMO
A pre-designed plasmid containing the gene encoding the second subunit of Echinococcus granulosus AgB8 (EgAgB8/2) was used to study the effect of the immunization route on the immune response in BALB/c mice. Mice were immunized with pDRIVEEgAgB8/2 or pDRIVE empty cassette using the intramuscular (i.m.), intranasal (i.n.) or the epidermal gene gun (g.g.) routes. Analysis of the antibody response and cytokine data revealed that gene immunization by the i.m. route induced a marked bias towards a T helper type 1 (Th1) immune response as characterized by high IFN-γ gene expression and a low IgG1/IgG2a reactivity index (R.I.) ratio of 0.04. The i.n. route showed a moderate IFN-γ expression but a higher IgG1/IgG2a R.I. ratio of 0.25 indicating a moderate Th1 response. In contrast, epidermal g.g. immunization induced a Th2 response characterized by high IL-4 expression and the highest IgG1/IgG2a R.I. ratio of 0.58. In conclusion, this study showed the advantage of genetic immunization using the i.m. route and i.n. over the epidermal g.g. routes in the induction of Th1 immunity in response to E. granulosus AgB gene immunization.
Assuntos
Equinococose/prevenção & controle , Echinococcus granulosus/imunologia , Lipoproteínas/imunologia , Células Th1/imunologia , Vacinas de DNA/administração & dosagem , Administração Intranasal , Animais , Anticorpos Anti-Helmínticos/biossíntese , Anticorpos Anti-Helmínticos/sangue , Biolística/métodos , Biolística/normas , DNA de Helmintos/imunologia , Echinococcus granulosus/genética , Feminino , Expressão Gênica , Imunização Secundária , Imunoglobulina G/biossíntese , Imunoglobulina G/sangue , Injeções Intramusculares , Interferon gama/biossíntese , Interferon gama/genética , Interleucina-4/biossíntese , Interleucina-4/genética , Lipoproteínas/administração & dosagem , Lipoproteínas/genética , Camundongos , Camundongos Endogâmicos BALB C , Plasmídeos , Ovinos , Doenças dos Ovinos/parasitologiaRESUMO
BACKGROUND: Filarial nematodes are tissue-dwelling parasites that can be killed by Th2-driven immune effectors, but that have evolved to withstand immune attack and establish chronic infections by suppressing host immunity. As a consequence, the efficacy of a vaccine against filariasis may depend on its capacity to counter parasite-driven immunomodulation. METHODOLOGY AND PRINCIPAL FINDINGS: We immunised mice with DNA plasmids expressing functionally-inactivated forms of two immunomodulatory molecules expressed by the filarial parasite Litomosoides sigmodontis: the abundant larval transcript-1 (LsALT) and cysteine protease inhibitor-2 (LsCPI). The mutant proteins enhanced antibody and cytokine responses to live parasite challenge, and led to more leukocyte recruitment to the site of infection than their native forms. The immune response was further enhanced when the antigens were targeted to dendritic cells using a single chain Fv-αDEC205 antibody and co-administered with plasmids that enhance T helper 2 immunity (IL-4) and antigen-presenting cell recruitment (Flt3L, MIP-1α). Mice immunised simultaneously against the mutated forms of LsALT and LsCPI eliminated adult parasites faster and consistently reduced peripheral microfilaraemia. A multifactorial analysis of the immune response revealed that protection was strongly correlated with the production of parasite-specific IgG1 and with the numbers of leukocytes present at the site of infection. CONCLUSIONS: We have developed a successful strategy for DNA vaccination against a nematode infection that specifically targets parasite-driven immunosuppression while simultaneously enhancing Th2 immune responses and parasite antigen presentation by dendritic cells.
Assuntos
Antígenos de Helmintos/imunologia , DNA de Helmintos/imunologia , Filariose/imunologia , Filariose/prevenção & controle , Filarioidea/imunologia , Vacinas de DNA/imunologia , Adjuvantes Imunológicos/administração & dosagem , Animais , Anticorpos Anti-Helmínticos/sangue , Antígenos de Helmintos/genética , Citocinas/metabolismo , DNA de Helmintos/administração & dosagem , DNA de Helmintos/genética , Modelos Animais de Doenças , Feminino , Filarioidea/genética , Linfócitos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Deleção de Sequência , Vacinas de DNA/administração & dosagem , Vacinas de DNA/genética , Vacinas de Subunidades Antigênicas/administração & dosagem , Vacinas de Subunidades Antigênicas/genética , Vacinas de Subunidades Antigênicas/imunologiaRESUMO
Genomic characterization of the genes encoding the Taenia 18 kDa/HP6 protective antigens was carried out for Taenia saginata and T. asiatica using 42 taeniid isolates comprising 23 samples of T. saginata, 13 samples of T. asiatica and 6 samples of T. solium. The corresponding sequences from all taeniid isolates were PCR-amplified with specific primers and then sequenced. All the genes, and other described taeniid gene homologues, had the same genomic structure. Surprisingly, the T. saginata TSA18 gene showed nucleotide variability within the 23 samples analyzed. This resulted in two distinct genotypes with 96% DNA sequence similarity and deduced amino acid sequences with 21 substitutions, mainly located in the second exon which contains the fibronectin type III domain. In regards to T. asiatica, the 18 kDa gene (TASI18) was very similar to the T. saginata antigen homologues, both at the DNA and deduced amino acid sequence levels, and the TSOL18 gene was conserved among T. solium isolates as previously described. The implications of these findings on the future development of taeniid vaccines are discussed.
Assuntos
Antígenos de Helmintos/genética , Taenia saginata/genética , Taenia solium/genética , África do Norte , Sequência de Aminoácidos , Substituição de Aminoácidos , Animais , Antígenos de Helmintos/imunologia , Antígenos de Helmintos/metabolismo , Ásia , Bovinos , Primers do DNA/química , DNA de Helmintos/genética , DNA de Helmintos/imunologia , Europa (Continente) , Éxons , Fibronectinas/química , Fibronectinas/genética , Variação Genética/imunologia , Humanos , América Latina , Dados de Sequência Molecular , Filogeografia , Reação em Cadeia da Polimerase , Estrutura Terciária de Proteína , Homologia de Sequência do Ácido Nucleico , Suínos , Taenia saginata/imunologia , Taenia saginata/isolamento & purificação , Taenia solium/imunologia , Taenia solium/isolamento & purificação , Teníase/genética , Teníase/imunologia , Teníase/prevenção & controle , Vacinas Sintéticas/biossínteseRESUMO
DNA vaccine encoding a multivalent antigen is a novel approach of protective immunization. Four Schistosoma japonicum candidate antigen genes, glyceraldehyde-3-phosphate dehydrogenase (SjGAPDH), 23 kDa transmembrane protein (Sj23), 14 kDa fatty-acid binding protein (SjFABP) and 26 kDa glutathione-S-transferase (Sj26), are recombined into two pieces of fusion genes SjFABP.Sj23 and Sj26.SjGAPDH, respectively. Tetravalent DNA vaccine pVIVO2-SjFABP.Sj23/Sj26.SjGAPDH is constructed by co-expressing these two fusion genes. The super-coiled DNA vaccines for large-scale clinic application were purified by sequential chromatographies including group separation chromatography and affinitive chromatographies. The purified DNA vaccines were evaluated for in vivo and in vitro transfection assay. The immunoprotective properties of the different kinds of constructed DNA vaccines were appraised by pharmacological trials. The pharmacological trials results showed that tetravalent DNA vaccine has higher protective efficiency than other tested DNA vaccines.
Assuntos
DNA de Helmintos/imunologia , Schistosoma japonicum/imunologia , Esquistossomose Japônica/prevenção & controle , Vacinas de DNA/imunologia , Animais , DNA de Helmintos/administração & dosagem , DNA de Helmintos/genética , Modelos Animais de Doenças , Proteínas de Helminto/genética , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Recombinantes de Fusão/genética , Schistosoma japonicum/genética , Esquistossomose Japônica/imunologia , Vacinas de DNA/administração & dosagem , Vacinas de DNA/genética , Vacinas Sintéticas/administração & dosagem , Vacinas Sintéticas/genética , Vacinas Sintéticas/imunologiaRESUMO
INTRODUCTION: We recently reported the biochemical characterization of a novel Fasciola hepatica recombinant antigen termed FhSAP2, which has previously shown to elicit protection to F. hepatica infection in rabbits. Further we reported that intramuscular (IM) injections of BALB/c mice with a pFLAG-CMV(-2) vector carrying cDNA encoding for FhSAP2 (cDNA-FhSAP2) induce high levels of immune response. The aim of the present study is to ascertain whether the immune response induced by this DNA construct may induce protection in mice against subsequent infection with F. hepatica metacercariae (mc). In addition, protection following subcutaneous (SC) injections with recombinant FhSAP2 was evaluated. METHODS: Mice received three IM injections with 100 microg of cDNA-FhSAP2 or three SC injections with 20 microg of FhSAP2. Four weeks after the last vaccination mice were challenged orally with 5 F. hepatica me and euthanized 45 days after challenge. RESULTS: Mean worm burdens found in mice vaccinated with cDNA-FhSAP2 was reduced by 83.3% and the mean worm burdens found in mice vaccinated with the recombinant protein was reduced by 60% when compared with controls. All vaccinated animals had less liver damage than challenge controls. Vaccination with cDNA-FhSAP2 seems to favor a mixed Th1/Th2-antibody dependent with higher predominance of Th1-regulated antibody response. CONCLUSIONS: The vaccination with cDNA-FhSAP2 or recombinant FhSAP2 may protect hosts against F. hepatica infections. The vaccination with cDNA form of FhSAP2 appeared to be a little more efficient preventingthe infection. The predominance of Th1-dependent antibodies in the vaccinated animals may be responsible for the protection but this should be confirmed by Th1-cytokines determinations.
Assuntos
Antígenos de Helmintos/imunologia , Fasciola hepatica/imunologia , Fasciolíase/imunologia , Animais , Anticorpos Anti-Helmínticos , Antígenos de Helmintos/administração & dosagem , DNA Complementar , DNA de Helmintos/imunologia , DNA Recombinante , Feminino , Injeções Intramusculares , Injeções Subcutâneas , Camundongos , Camundongos Endogâmicos BALB C , Plasmídeos , Proteínas Recombinantes/imunologia , Saposinas/imunologia , Vacinação , Vacinas SintéticasRESUMO
BACKGROUND: Anisakis simplex is a nematode which can parasitize humans, producing anisakiasis and can induce immunoglobulin-(Ig)-E-mediated allergic symptoms. Parasite recombinant proteins, such as the major allergen Ani s 1, may be useful tools to avoid misdiagnosis of A simplex allergy due to cross-reactivity when whole parasite extracts are used. OBJECTIVE: To obtain Ani s 1 allergen as a recombinant protein with IgE-binding properties similar to its natural counterpart. METHODS: Ani s 1-encoding cDNA was amplified by polymerase chain reaction and cloned. The allergen was expressed in Escherichia coli as a nonfusion protein. Natural and recombinant Ani s 1 were investigated by means of Western blotting, enzyme allergosorbent test, enzyme-linked immunosorbent assay (ELISA), and ELISA inhibition using sera from 53 patients with A simplex allergy. RESULTS: Residues of the amino acid sequence of the encoded protein were 99.4% identical to the reported one. Purified rAni s 1 was obtained with a yield of 2 mg/L of culture while the yield of the natural counterpart was only 50 micro/g of larvae. rAni s 1 reactivity was not significantly different from that of the natural allergen; the correlation was excellent (p = 0.92, P < .001). ELISA-inhibition experiments showed that the dose-response inhibition curve obtained with rAni s 1 overlapped with that of nAni s 1. In an enzyme allergosorbent analysis, 86.8% of the A simplex-allergic patient sera reacted to rAni s 1. CONCLUSION: Recombinant Ani s 1 is immunochemically equivalent to its natural counterpart and therefore might be useful for the in vitro diagnosis of anisakiasis and A simplex-mediated allergy.
Assuntos
Alérgenos/biossíntese , Alérgenos/genética , Anisaquíase/diagnóstico , Anisakis , Anticorpos Anti-Helmínticos/imunologia , Antígenos de Helmintos/genética , Antígenos de Helmintos/imunologia , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia , Alérgenos/imunologia , Animais , Anisaquíase/sangue , Anisaquíase/imunologia , Anticorpos Anti-Helmínticos/sangue , Anticorpos Anti-Helmínticos/genética , Antígenos de Helmintos/biossíntese , Proteínas de Ligação ao Cálcio/biossíntese , Proteínas de Ligação ao Cálcio/genética , Proteínas de Ligação ao Cálcio/imunologia , DNA de Helmintos/genética , DNA de Helmintos/imunologia , Escherichia coli , Proteínas de Helminto/biossíntese , Proteínas de Helminto/genética , Proteínas de Helminto/imunologia , Humanos , Hipersensibilidade Imediata/diagnóstico , Hipersensibilidade Imediata/parasitologia , Imunoquímica , Imunoglobulina E/sangue , Imunoglobulina E/genética , Proteínas Recombinantes/biossínteseRESUMO
Immunization of jirds with Bm-alt-2 elicited partial protection against challenge infection with the filarial parasite Brugia malayi. In this study, we initially compared the protective immune responses elicited following immunization with recombinant Bm-ALT-2 protein regimen and Bm-alt-2 DNA regimen. These studies showed that protein vaccination conferred approximately 75% protection compared to DNA vaccination that conferred only 57% protection. Analysis of the protective immune responses showed that the protein immunization promoted a Th2-biased response with an increase in IL-4, IL-5 and IgG1 responses, whereas, the DNA vaccine promoted a Th1-biased response with profound IFN-gamma and IgG2a responses. Since protein vaccination gave better results than DNA vaccination, we then wanted to evaluate whether a prime-boost vaccination that combined DNA prime and protein boost will significantly increase the protective responses induced by the protein vaccine. Our results suggest that prime-boost vaccination had no added advantage and was comparatively less effective (64% protection) than the Bm-ALT-2 protein alone vaccination. Prime boost vaccination generated mixed Th1/Th2 responses with a slightly diminished Th2 responses compared to protein vaccination. Thus, our results suggest that Bm-ALT-2 protein vaccination regimen may be slightly better than prime-boost vaccine regimen and the mechanism of protection appears to be largely mediated by a Th2-biased response.
Assuntos
Anticorpos Anti-Helmínticos/biossíntese , Antígenos de Helmintos/imunologia , Brugia Malayi/imunologia , Filariose Linfática/prevenção & controle , Proteínas de Helminto/imunologia , Proteínas Recombinantes/imunologia , Vacinas/imunologia , Animais , Anticorpos Anti-Helmínticos/sangue , Antígenos de Helmintos/genética , Citocinas/biossíntese , Citocinas/genética , DNA de Helmintos/imunologia , Cultura em Câmaras de Difusão , Modelos Animais de Doenças , Gerbillinae , Proteínas de Helminto/genética , Imunidade Celular , Imunização/métodos , Ativação Linfocitária , Masculino , Proteínas Recombinantes/genética , Células Th2/imunologia , Vacinas de DNA/imunologia , Vacinas Sintéticas/imunologiaRESUMO
In the search for Onchocerca volvulus antigens possibly involved in protection against human onchocerciasis, partial amino acid sequence analysis of one of the O. volvulus antigens of the serologically identified proteins showed a close relationship to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein family. Subsequent adult worm cDNA library screening and cloning produced a clone of 1650 bp. An open reading frame spans over 1020 bp encoding for a protein of 340 amino acids with an apparent molecular weight of 38000. Comparison of the complete amino acid sequence identified this protein as a member of the GAPDH protein family. The recombinantly expressed protein shows GAPDH enzymatic activity as well as plasminogen-binding capacity. DNA sequence analysis of the corresponding gene revealed the presence of two introns. Using immunohistology Ov-GAPDH was observed in microfilariae, infective larvae, and adult male and female worms. Most striking was the labelling of the musculature of the body wall. Labelling was also observed in the pseudocoeloma cavity and in a subset of cell nuclei, suggesting additional, non-glycolytic functions of the Ov-GAPDH. Gene gun immunization with the DNA-construct in cattle led to specific humoral immune responses. Thus, the protective potential of the DNA-construct of Ov-GAPDH can be evaluated in vaccination trials using animal models such as the cattle/Onchocerca ochengi model.
Assuntos
Clonagem Molecular , DNA de Helmintos/imunologia , Gliceraldeído-3-Fosfato Desidrogenases/imunologia , Imunização , Onchocerca volvulus/enzimologia , Sequência de Aminoácidos , Animais , Anticorpos Anti-Helmínticos/sangue , Sequência de Bases , Bovinos , Gliceraldeído-3-Fosfato Desidrogenases/química , Gliceraldeído-3-Fosfato Desidrogenases/genética , Gliceraldeído-3-Fosfato Desidrogenases/isolamento & purificação , Gliceraldeído-3-Fosfato Desidrogenases/metabolismo , Imunoglobulina G/sangue , Imunoglobulina G/classificação , Imuno-Histoquímica , Íntrons , Dados de Sequência Molecular , Peso Molecular , Fases de Leitura Aberta , Coelhos , Proteínas Recombinantes/química , Proteínas Recombinantes/imunologia , Proteínas Recombinantes/isolamento & purificação , Proteínas Recombinantes/metabolismo , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos , Homologia de Sequência do Ácido Nucleico , Fatores de Tempo , Vacinas Sintéticas/imunologiaRESUMO
Neutrophils, eosinophils and macrophages interact with invading parasites and naive hosts. The initial reaction of leukocytes is the generation of reactive oxygen species (ROS). The cytotoxic effects of extracts derived from intact Cysticercus cellulosae and from the scolex or membrane fractions on neutrophils were examined. DNA fragmentation of neutrophils was observed when cells were incubated with an extract from the intact metacestode; however, the addition of antioxidant enzymes to the incubation medium had a protective effect. The scolex and membrane extracts did not affect DNA fragmentation of neutrophils. Hydrogen peroxide production of neutrophils incubated with metacestode fractions from C. cellulosae increased by 190% (total extract), 120% (scolex) or 44% (membrane). An increase in antioxidant catalase activity (28%) concomitant with the increased production of ROS was observed in neutrophils incubated with metacestode fractions, which could be an attempt at self-protection. ROS production by neutrophils in the presence of the intact cysticerci extract did not alter phagocytosis. In contrast, the scolex and membrane fractions increased the phagocytic capacity of neutrophils by 44 and 28%, respectively. The results showed that the extract from intact C. cellulosae was toxic for neutrophils via ROS production, leading to DNA fragmentation and inhibition of phagocytic capacity, but neutrophils are able to protect themselves against oxidative stress by via catalase activity.
Assuntos
Cysticercus/imunologia , Fragmentação do DNA , DNA de Helmintos/imunologia , Neutrófilos/fisiologia , Neutrófilos/parasitologia , Espécies Reativas de Oxigênio/metabolismo , Animais , Catalase/metabolismo , Células Cultivadas , Cisticercose/parasitologia , Cisticercose/veterinária , Cysticercus/enzimologia , Cysticercus/genética , Citometria de Fluxo/veterinária , Glutationa Peroxidase/metabolismo , Peróxido de Hidrogênio/metabolismo , Masculino , Neutrófilos/enzimologia , Estresse Oxidativo , Fagocitose , Superóxido Dismutase/metabolismo , Suínos , Doenças dos Suínos/parasitologiaRESUMO
Vaccination with a membrane-bound thiol Sepharose-binding fraction (TSBP) of adult Haemonchus contortus has been shown to confer significant levels of protection against homologous challenge in sheep. This fraction is greatly enriched for cysteine proteinase activity. Following fractionation of TSBP by anion-exchange chromatography on MonoQ, protection was found to partition with those fractions further enriched for cysteine proteinase activity. In this study, the cysteine proteinases of adult H. contortus TSBP were specifically purified by affinity chromatography using recombinant H. contortus cystatin, a potent cysteine proteinase inhibitor. Although only 1-1.5% of total TSBP bound to cystatin-Sepharose, this fraction contained 100% of the cysteine proteinase activity, as determined by gelatin substrate gel analysis. When used to immunise sheep, less than 3microg per dose of this cysteine proteinase fraction was found to confer a substantial and repeatable level of protection against homologous challenge infection, reducing faecal egg counts by 48 and 28% and worm burdens by 44 and 46% over two trials. Host serum immunoglobulin levels and abomasal mast cell and eosinophil numbers were evaluated, although no correlation with protection was observed. Three cathepsin B-like cysteine proteinases present in TSBP (hmcp1, 4 and 6) have been identified previously by cDNA library immunoscreening. The predicted mature forms of these three cysteine proteinases were expressed in bacteria as insoluble, GST-fusion proteins. Following solubilisation in urea/DTT, the protective capacity of a cocktail of recombinant proteins was evaluated in sheep. Although no reduction in faecal egg counts was observed, sheep vaccinated with recombinant cysteine proteinases showed a highly significant 38% reduction (P <0.01) in worm burdens.
Assuntos
Cisteína Endopeptidases/imunologia , Hemoncose/imunologia , Hemoncose/veterinária , Haemonchus/imunologia , Doenças dos Ovinos/imunologia , Doenças dos Ovinos/prevenção & controle , Vacinas Sintéticas/imunologia , Animais , Antígenos de Helmintos/imunologia , Western Blotting , Cromatografia de Afinidade , Cistatinas/química , Cistatinas/imunologia , Cisteína Endopeptidases/isolamento & purificação , DNA de Helmintos/química , DNA de Helmintos/genética , DNA de Helmintos/imunologia , Ensaio de Imunoadsorção Enzimática , Fezes/parasitologia , Glutationa Transferase/imunologia , Hemoncose/prevenção & controle , Haemonchus/química , Imunoglobulina A/imunologia , Imunoglobulina E/imunologia , Imunoglobulina G/imunologia , Membranas/imunologia , Proteínas Recombinantes de Fusão/imunologia , Sefarose/química , OvinosRESUMO
Flow cytometry analysis of leukocytes response in rats immunized and infected with Fasciola hepatica. In the present experiment the differences in blood leucocytes between rats immunised intranasally with cDNA encoding F. hepatica GST, challenged with the parasite (group 1) and non-immunised infected rats (group 2) were compared. The number of leukocytes were estimated by flow cytometry on the 1, 5, 9 week after infection. Changes in the level of blood lymphocytes and monocytes were similar, with an increasing tendency in both groups. The level of eosinophils decreased to the 9th week after infection in both groups, however the number of these cells was seven times higher in control rats than in immunised rats.
Assuntos
Fasciola hepatica , Fasciolíase/imunologia , Leucócitos/imunologia , Animais , DNA de Helmintos/imunologia , Fasciolíase/prevenção & controle , Feminino , Citometria de Fluxo , Imunização/métodos , Contagem de Leucócitos , Leucócitos/parasitologia , Masculino , Ratos , Ratos Endogâmicos , Vacinas de DNA/imunologiaRESUMO
Our previous experiments have shown that intramuscular injection of Sprague-Dawley rats with a pcDNA 3.1 vector carrying cDNA encoding for a cysteine proteinase (CP) of F. hepatica may induce a high level of protection against subsequent infection with F. hepatica metacercariae (mc). The aim of the present study is to compare the immune response of Sprague-Dawley rats vaccinated intranasally with plasmid containing cDNA of CP of the fluke and intramuscularly or intraperitoneally with the recombinated enzyme protein to challenge with fluke metacercariae. In addition, protection following intranasal DNA vaccination was evaluated. Two experiments were carried out. In the first experiment rats were vaccinated twice with 50microg of cDNA containing plasmid or with 100microg protein of recombinated CP. Three weeks after the second vaccination rats were challenged orally with 25 mc. On days 0, 21, 42 and 63 after the challenge blood samples were collected for the evaluation of white blood cell, eosinophil and specific antibody responses. During the second experiment groups of five male and female rats were vaccinated twice intranasally with CPcDNA then challenged with 30 mc and dissected 5 weeks later. Results obtained in the experiments suggested that intranasal immunisation of rats with CPcDNA seems to favour a Th2 regulated antibody response. Intramuscular or intraperitoneal injections of CP protein stimulate both Th1 and Th2-dependent antibodies. Mean worm burdens found in rats vaccinated intranasally 5 or 10 weeks after the challenge were reduced by 61-75% in comparison with the challenge controls which suggests that intranasal vaccination with CPcDNA may protect hosts against F. hepatica infection.
Assuntos
Cisteína Endopeptidases/genética , Cisteína Endopeptidases/imunologia , DNA de Helmintos/imunologia , Fasciola hepatica/imunologia , Fasciolíase/imunologia , Vacinas/imunologia , Animais , Anticorpos Anti-Helmínticos/imunologia , DNA Complementar/genética , Eosinófilos/imunologia , Leucócitos/imunologia , Ratos , Ratos Sprague-Dawley , Vacinas/administração & dosagem , Vacinas de DNA/administração & dosagem , Vacinas de DNA/imunologiaRESUMO
OBJECTIVE: To construct and express DNA plasmid of Trichinella spiralis. METHODS: The BamHI and HindIII enzyme sites and KOZAK sequences were introduced at both ends of Ts87 gene by PCR. Ts87 gene was ligated into pcDNA3.1(+) vector with T4 ligase. The recombinant plasmid pcDNA3.1/Ts87 and plasmid pcDNA3.1 were transfected into an eukaryotic cell line COS7 through Lipofectamine, respectively. The BALB/c mice were immunized with the purified plasmid DNA pcDNA3.1/Ts87 through two routes: intramuscular injection and gene-gun injection. RESULTS AND CONCLUSION: The pcDNA3.1/Ts87 was expressed both in COS7 and in the BALB/c mice.
Assuntos
DNA de Helmintos/genética , Plasmídeos/genética , Trichinella spiralis/genética , Animais , Células COS , Chlorocebus aethiops , DNA de Helmintos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Plasmídeos/imunologia , Coelhos , Transfecção , Trichinella spiralis/imunologia , Vacinas de DNARESUMO
OBJECTIVE: To understand and identify the molecules related to the self-cure of Schistosoma japonicum infection in water buffaloes. METHODS: The S. japonicum adult worm cDNA library was immunologically screened with the sera of self-cured water buffaloes. The positive clones were identified, cloned, sequenced and analysed with software. RESULTS: Three genes encoding antigens relevant to sera antibodies in water buffaloes were cloned and sequenced. These antigens included paramyosin (Sj97), GST, carbonyl reductase-like 20-beta-hydroxysteroid dehydrogenase(CR/20-beta-HSD). CONCLUSION: Sera from self-cured S. japonicum infected water buffaloes can be used to screen adult worm cDNA library for vaccine development.
Assuntos
Búfalos/imunologia , DNA Complementar/imunologia , DNA de Helmintos/imunologia , Schistosoma japonicum/genética , Animais , Biblioteca Gênica , Soros Imunes/imunologia , Schistosoma japonicum/imunologia , Esquistossomose Japônica/imunologia , Vacinas de DNA/imunologiaRESUMO
This study investigated the protective capacity of the recombinant Taenia saginata Tso18 antigen administered as a DNA vaccine in the Taenia crassiceps murine model of cysticercosis. This Tso18 DNA sequence, isolated from a T. saginata oncosphere cDNA library, has homologies with Taenia solium and Echinococcus sp. It was cloned in the pcDNA3.1 plasmid and injected once intramuscularly into mice. Compared to saline-vaccinated control mice, immunization reduced the parasite burden by 57.3-81.4%, while lower levels of non-specific protection were induced in control mice injected with the plasmid pcDNA3.1 (18.8-33.1%) or a plasmid with irrelevant construct, pcDNA3.1/3D15 (33.4-38.8%). Importantly, significant levels of protection were observed between the pcDNA3.1/Tso18 plasmid and pcDNA3.1/3D15 plasmid immunized mice. Mice immunized with pTso18 synthesized low levels of, primarily IgG1 sub-class, antibodies. These antibodies were shown to recognize a 66 kDa antigen fraction of T. crassiceps and T. solium. Splenocytes enriched in both CD4+CD8- and CD4-CD8+ T cells from these vaccinated mice proliferated in vitro when exposed to antigens from both T. solium and T. crassiceps cestodes. Immunolocalization studies revealed the Tso18 antigen in oncospheres of T. saginata and T. solium, in the adult tapeworm and in the tegument of T. solium cysticerci. The protective capacity of this antigen and its extensive distribution in different stages, species and genera of cestodes points to the potential of Tso18 antigen for the possible design of a vaccine against cestodes.